Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03285854
Other study ID # 15HM36
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date February 1, 2017
Est. completion date December 30, 2022

Study information

Verified date March 2022
Source Great Ormond Street Hospital for Children NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a novel, non-invasive method of assessing Ca balance by natural Ca isotope fractionation.


Description:

Detailed description and study protocol will be available to individuals on request.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 120
Est. completion date December 30, 2022
Est. primary completion date December 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 18 Years
Eligibility I - For healthy children Inclusion criteria - All children <18 years - Normal renal function (eGFR 90-120ml/min/1.73m2 [calculated by Schwartz formula] in children >1 year and serum creatinine <35µMol/L in children <1 year) - Weight, height and BMI within 2 SD of normal using WHO growth charts In order to make this study as 'real-life' as possible, free-living UK children on their usual diet and dietary supplementation (including Ca and Vit D), if any, will be included, but analysis will account for medication doses and blood levels. Exclusion criteria - Pre-existing bone disease - inherited or acquired - Fractures in the preceding 6 months - Glucocorticoid therapy in the preceding year, or a lifetime cumulative steroid exposure =6 months - Bisphosphonate therapy at any time in the past - Any acute illness in the preceding 2 weeks (when the child is unable to maintain their usual diet or has bed rest) II - For CKD and dialysis children Inclusion criteria - Children of all ages with an eGFR <60ml/min/1.73m2, including those on dialysis. Exclusion criteria - As listed above for healthy children.

Study Design


Intervention

Diagnostic Test:
Collection of blood, urine and stool samples
Collection of blood, urine and stool samples, diet diary and bone scans

Locations

Country Name City State
United Kingdom Great Ormond Street Hospital for Children NHS Foundation Trust London

Sponsors (4)

Lead Sponsor Collaborator
Great Ormond Street Hospital for Children NHS Foundation Trust Athens General Children's Hospital "Pan. & Aglaia Kyriakou", Cukurova University, University of Kiel

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Calcium isotope fractionation in blood, urine and stool in healthy children and those with CKD available on request 24 months
Primary number of children with fractures, and clinical and biochemical correlates of fractures available on request 12 months
Primary Bone scans - whole body & lumbar spine DEXA, bone mineral density on tibial peripheral quantitative CT scan available on request 24 months
See also
  Status Clinical Trial Phase
Completed NCT03960437 - The Effect of Etelcalcetide on CKD-MBD Phase 2
Completed NCT03937349 - Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
Completed NCT03626246 - Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
Completed NCT02697578 - Artificial Intelligence: a New Alternative to Analyse CKD-MBD in Hemodialysis
Active, not recruiting NCT04019379 - Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease N/A
Active, not recruiting NCT03108222 - Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease